Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 | 36.16 | |
2 | Molecular Cancer | journal | 3.274 Q1 | 196 | 164 | 449 | 11755 | 4299 | 434 | 10.87 | 71.68 | 41.42 | |
3 | Oncogene | journal | 3.127 Q1 | 370 | 462 | 1751 | 25124 | 11324 | 1743 | 6.42 | 54.38 | 40.79 | |
4 | Journal of Hematology and Oncology | journal | 2.960 Q1 | 144 | 135 | 425 | 8852 | 3345 | 417 | 8.51 | 65.57 | 44.16 | |
5 | Breast Cancer Research | journal | 2.874 Q1 | 175 | 151 | 397 | 6656 | 2483 | 380 | 5.59 | 44.08 | 52.65 | |
6 | Cell Death and Disease | journal | 2.310 Q1 | 164 | 1137 | 1499 | 56732 | 8763 | 1390 | 5.61 | 49.90 | 43.20 | |
7 | Journal of Experimental and Clinical Cancer Research | journal | 1.761 Q1 | 120 | 281 | 497 | 14600 | 2678 | 497 | 5.30 | 51.96 | 44.58 | |
8 | Molecular Therapy - Oncolytics | journal | 1.753 Q1 | 42 | 29 | 94 | 1314 | 488 | 93 | 5.79 | 45.31 | 42.06 | |
9 | Cancer Medicine | journal | 1.425 Q2 | 84 | 588 | 853 | 22359 | 3195 | 845 | 3.52 | 38.03 | 40.28 | |
10 | BMC Cancer | journal | 1.336 Q2 | 160 | 1277 | 2837 | 50327 | 9779 | 2833 | 3.11 | 39.41 | 41.88 | |
11 | Cancer Cell International | journal | 1.180 Q2 | 80 | 212 | 314 | 9417 | 1223 | 314 | 3.49 | 44.42 | 42.01 | |
12 | Experimental Hematology and Oncology | journal | 0.988 Q3 | 42 | 33 | 95 | 1255 | 283 | 92 | 3.02 | 38.03 | 43.91 | |
13 | International Journal of Hyperthermia | journal | 0.988 Q3 | 98 | 237 | 336 | 9195 | 1209 | 314 | 3.47 | 38.80 | 31.65 | |
14 | Infectious Agents and Cancer | journal | 0.901 Q3 | 47 | 43 | 163 | 1777 | 410 | 163 | 2.61 | 41.33 | 46.53 | |
15 | Molecular and Cellular Oncology | journal | 0.877 Q3 | 37 | 126 | 465 | 1278 | 755 | 400 | 1.31 | 10.14 | 42.61 | |
16 | ecancermedicalscience | journal | 0.758 Q3 | 47 | 102 | 305 | 3451 | 599 | 305 | 1.87 | 33.83 | 39.31 | |
17 | Cancer Treatment and Research Communications | journal | 0.297 Q4 | 23 | 31 | 138 | 953 | 76 | 137 | 0.62 | 30.74 | 45.00 | |
18 | European Journal of Cancer, Supplement | journal | 0.256 Q4 | 29 | 0 | 10 | 0 | 9 | 10 | 9.00 | 0.00 | 0.00 | |
19 | Cancer Communications | journal | 0.124 Q4 | 79 | 74 | 221 | 3189 | 790 | 190 | 3.34 | 43.09 | 40.43 | |
20 | Cancer Reports | journal | 18 | 20 | 0 | 846 | 0 | 0 | 0.00 | 42.30 | 39.58 | ||
21 | Cell Death Discovery | journal | 58 | 124 | 249 | 5686 | 811 | 221 | 3.19 | 45.85 | 37.50 | ||
22 | ESMO Open | journal | 60 | 114 | 190 | 3028 | 649 | 146 | 3.42 | 26.56 | 34.62 | ||
23 | npj Precision Oncology | journal | 36 | 27 | 1 | 1764 | 4 | 1 | 4.00 | 65.33 | 44.31 | ||
24 | Signal Transduction and Targeted Therapy | journal | 117 | 31 | 58 | 2821 | 350 | 54 | 6.03 | 91.00 | 39.70 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®